RNA-Seq data mining: downregulation of NeuroD6 serves as a possible biomarker for alzheimer's disease brains
- PMID: 25548427
- PMCID: PMC4274867
- DOI: 10.1155/2014/123165
RNA-Seq data mining: downregulation of NeuroD6 serves as a possible biomarker for alzheimer's disease brains
Abstract
Alzheimer's disease (AD) is the most common cause of dementia worldwide with no curative therapies currently available. Previously, global transcriptome analysis of AD brains by microarray failed to identify the set of consistently deregulated genes for biomarker development of AD. Therefore, the molecular pathogenesis of AD remains largely unknown. Whole RNA sequencing (RNA-Seq) is an innovative technology for the comprehensive transcriptome profiling on a genome-wide scale that overcomes several drawbacks of the microarray-based approach. To identify biomarker genes for AD, we analyzed a RNA-Seq dataset composed of the comprehensive transcriptome of autopsized AD brains derived from two independent cohorts. We identified the core set of 522 genes deregulated in AD brains shared between both, compared with normal control subjects. They included downregulation of neuronal differentiation 6 (NeuroD6), a basic helix-loop-helix (bHLH) transcription factor involved in neuronal development, differentiation, and survival in AD brains of both cohorts. We verified the results of RNA-Seq by analyzing three microarray datasets of AD brains different in brain regions, ethnicities, and microarray platforms. Thus, both RNA-Seq and microarray data analysis indicated consistent downregulation of NeuroD6 in AD brains. These results suggested that downregulation of NeuroD6 serves as a possible biomarker for AD brains.
Figures
Similar articles
-
Systems analysis of human brain gene expression: mechanisms for HIV-associated neurocognitive impairment and common pathways with Alzheimer's disease.BMC Med Genomics. 2013 Feb 13;6:4. doi: 10.1186/1755-8794-6-4. BMC Med Genomics. 2013. PMID: 23406646 Free PMC article.
-
Transcriptome-wide piRNA profiling in human brains of Alzheimer's disease.Neurobiol Aging. 2017 Sep;57:170-177. doi: 10.1016/j.neurobiolaging.2017.05.020. Epub 2017 Jun 3. Neurobiol Aging. 2017. PMID: 28654860 Free PMC article.
-
NeuroD6 genomic signature bridging neuronal differentiation to survival via the molecular chaperone network.J Neurosci Res. 2010 Jan;88(1):33-54. doi: 10.1002/jnr.22182. J Neurosci Res. 2010. PMID: 19610105 Free PMC article.
-
A Meta-Analysis of Alzheimer's Disease Brain Transcriptomic Data.J Alzheimers Dis. 2019;68(4):1635-1656. doi: 10.3233/JAD-181085. J Alzheimers Dis. 2019. PMID: 30909231 Free PMC article.
-
Understanding the pathogenesis of Alzheimer's disease: will RNA-Seq realize the promise of transcriptomics?J Neurochem. 2011 Mar;116(6):937-46. doi: 10.1111/j.1471-4159.2010.07157.x. Epub 2011 Jan 19. J Neurochem. 2011. PMID: 21175619 Review.
Cited by
-
Integrated genomic approaches identify major pathways and upstream regulators in late onset Alzheimer's disease.Sci Rep. 2015 Jul 23;5:12393. doi: 10.1038/srep12393. Sci Rep. 2015. PMID: 26202100 Free PMC article.
-
RNA-Sequencing Analysis Reveals a Regulatory Role for Transcription Factor Fezf2 in the Mature Motor Cortex.Front Mol Neurosci. 2017 Sep 7;10:283. doi: 10.3389/fnmol.2017.00283. eCollection 2017. Front Mol Neurosci. 2017. PMID: 28936162 Free PMC article.
-
The bHLH Transcription Factors in Neural Development and Therapeutic Applications for Neurodegenerative Diseases.Int J Mol Sci. 2022 Nov 11;23(22):13936. doi: 10.3390/ijms232213936. Int J Mol Sci. 2022. PMID: 36430421 Free PMC article. Review.
-
Regulation of Life & Death by REGγ.Cells. 2022 Jul 23;11(15):2281. doi: 10.3390/cells11152281. Cells. 2022. PMID: 35892577 Free PMC article. Review.
-
Modulating Mitochondrial Dynamics Mitigates Cognitive Impairment in Rats with Myocardial Infarction.Curr Neuropharmacol. 2024;22(10):1749-1760. doi: 10.2174/1570159X22666240131114913. Curr Neuropharmacol. 2024. PMID: 38362882 Free PMC article.
References
-
- Jonsson T., Atwal J. K., Steinberg S., Snaedal J., Jonsson P. V., Bjornsson S., Stefansson H., Sulem P., Gudbjartsson D., Maloney J., Hoyte K., Gustafson A., Liu Y., Lu Y., Bhangale T., Graham R. R., Huttenlocher J., Bjornsdottir G., Andreassen O. A., Jönsson E. G., Palotie A., Behrens T. W., Magnusson O. T., Kong A., Thorsteinsdottir U., Watts R. J., Stefansson K. A mutation in APP protects against Alzheimer's disease and age-related cognitive decline. Nature. 2012;487(7409):96–99. doi: 10.1038/nature11283. - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
